Cytokinetics · 16 hours ago
Intern - Pharmacology
Cytokinetics is a specialty cardiovascular biopharmaceutical company focused on advancing new medicines for patients with cardiac muscle dysfunction. The Pharmacology internship offers hands-on experience in preclinical data related to cardiac biology, involving in vivo and in vitro experiments and collaboration with researchers.
BiopharmaBiotechnologyHealth Care
Responsibilities
Literature review and study design
Work with fellow pharmacology team members to conduct pre-clinical studies, including biomarker sample analysis
Monitor study progression and summarize the results
Maintain accurate experimental records and contribute to data summaries and presentations
Participate in Pharmacology team meetings and collaborative discussions
Deliver a final presentation summarizing findings at the conclusion of the program
Qualification
Required
At least two to four years at a US college or university at the time of the program
Completed coursework in biology, physiology, pharmacology, or a related life science discipline
Basic laboratory skill experience (e.g., pipetting, preparing physiological buffers) required
Prior animal handling experience is desirable; a willingness to learn to handle rodents is required
Detail oriented and have a proactive attitude in support of research activities and running assays
Highly focused, organized and motivated team player with good time management skills
Excellent communication skills and the ability to troubleshoot problems with team members
Preferred
Experience with data management tools and presentation skills preferred
Company
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
H1B Sponsorship
Cytokinetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (9)
2024 (9)
2023 (4)
2022 (6)
2021 (7)
2020 (4)
Funding
Current Stage
Public CompanyTotal Funding
$2.41BKey Investors
Royalty PharmaDeerfieldVulcan
2025-09-16Post Ipo Debt· $650M
2024-05-22Post Ipo Equity· $550M
2024-05-22Post Ipo Debt· $50M
Recent News
GlobeNewswire
2026-01-13
Company data provided by crunchbase